showed that M2-Exos delivered miR-3679-5p to LC cells and reduced NEDD4L-mediated c-Myc ubiquitination by inhibiting NEDD4L transcription, promoting aerobic glycolysis in LC cells, and inducing chemoresistance (135). The gene discussed is MYC; the disease is laryngotracheoesophageal cleft.